These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 21867834)

  • 21. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
    Ricci RP; Quesada A; Almendral J; Arribas F; Wolpert C; Adragao P; Zoni-Berisso M; Navarro X; DeSanto T; Grammatico A; Santini M;
    Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation.
    Wei S; Loyo-Berríos NI; Haigney MC; Cheng H; Pinnow EE; Mitchell KR; Beachy JH; Woodward AM; Wang Y; Curtis JP; Marinac-Dabic D
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):346-54. PubMed ID: 21487093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.
    Lampert R; Wang Y; Curtis JP
    Am Heart J; 2013 Jun; 165(6):1015-1023.e2. PubMed ID: 23708175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE; Gleva MJ; Mela T; Chung MK; Uslan DZ; Borge R; Gottipaty V; Shinn T; Dan D; Feldman LA; Seide H; Winston SA; Gallagher JJ; Langberg JJ; Mitchell K; Holcomb R;
    Circulation; 2010 Oct; 122(16):1553-61. PubMed ID: 20921437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
    Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
    Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
    Russo AM; Daugherty SL; Masoudi FA; Wang Y; Curtis J; Lampert R
    Am Heart J; 2015 Aug; 170(2):330-8. PubMed ID: 26299231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in device therapy for malignant ventricular arrhythmias.
    Horton HL; Marinchak RA; Rials SJ; Kowey PR
    Arch Intern Med; 1995 Nov; 155(21):2342-5. PubMed ID: 7487260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual Report 2012].
    Proclemer A; Zecchin M; Lunati M; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2013 Nov; 14(11):784-96. PubMed ID: 24326641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
    MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
    Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.
    Margolis G; Hamuda N; Kobo O; Elbaz Greener G; Amir O; Homoud M; Madias C; Heist EK; Ruskin JN; Kazatsker M; Roguin A; Leshem E; Rozen G
    J Am Heart Assoc; 2023 Aug; 12(15):e029126. PubMed ID: 37522389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.
    Prutkin JM; Reynolds MR; Bao H; Curtis JP; Al-Khatib SM; Aggarwal S; Uslan DZ
    Circulation; 2014 Sep; 130(13):1037-43. PubMed ID: 25081281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
    Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
    Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
    Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spanish implantable cardioverter-defibrillator registry. 5th official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2008).
    Peinado R; Torrecilla EG; Ormaetxe J; Alvarez M; Cózar R; Alzueta J;
    Rev Esp Cardiol; 2009 Dec; 62(12):1435-49. PubMed ID: 20038409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.
    Duray GZ; Schmitt J; Cicek-Hartvig S; Hohnloser SH; Israel CW
    Europace; 2009 Mar; 11(3):297-302. PubMed ID: 19054788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study.
    Proclemer A; Muser D; Campana A; Zoni-Berisso M; Zecchin M; Locatelli A; Brieda M; Gramegna L; Santarone M; Chiodi L; Mazzone P; Rebellato L; Facchin D
    Int J Cardiol; 2013 Sep; 168(2):1416-21. PubMed ID: 23287697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals.
    Tsai V; Goldstein MK; Hsia HH; Wang Y; Curtis J; Heidenreich PA;
    J Am Geriatr Soc; 2011 Sep; 59(9):1589-95. PubMed ID: 21883101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.